Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8<sup>+</sup> T cell immunity against bulky tumors via an IFN-I/NK/DC axis.

Nature communications·2026
Same author

Association between sarcopenic obesity and mild cognitive impairment in patients with type 2 diabetes mellitus.

Frontiers in nutrition·2026
Same author

Predictive value of folate receptor-positive circulating tumor cells in postoperative progressive disease of non-small cell lung cancer patients.

Journal of cancer research and clinical oncology·2026
Same author

How psychological distance shapes ecological farming: cognitive-social mechanisms in smallholder decision-making.

Journal of the science of food and agriculture·2026
Same author

Weight-Controllable Biobarcode Probes for Multi-input Breast Cancer Diagnosis.

Nano letters·2026
Same author

Conformational Snapshots of CydDC in a Native Lipid Bilayer Coupling Heme Transport to Antibiotic Resistance.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: Jun 2, 2026

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.2K

Transcriptomic Determinants of Circulating Immunity Predict Immune-Related Adverse Events (irAEs) in Cancer Patients

Liting You1,2,3,4, Jianzhao Zhai1,2,3, Zhaodan Xin1,2,3

  • 1Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.

Thoracic Cancer
|April 1, 2026
PubMed
Summary

This study identifies five novel biomarkers in peripheral blood mononuclear cells (PBMCs) that can predict immune-related adverse events (irAEs) in cancer patients undergoing immune checkpoint inhibitor (ICI) therapy. These findings offer potential for improved patient management and targeted treatments.

Keywords:
FXYD7circulating transcriptomeimmune checkpoint inhibitorsimmune‐related adverse events

More Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.0K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Related Experiment Videos

Last Updated: Jun 2, 2026

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.2K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

6.0K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.5K

Area of Science:

  • Immunology
  • Oncology
  • Genomics

Background:

  • Immune checkpoint inhibitor (ICI) therapy has shown success in treating solid tumors.
  • Immune-related adverse events (irAEs) present significant challenges in managing ICI therapy.
  • Reliable biomarkers for predicting irAEs are currently limited.

Purpose of the Study:

  • To identify novel biomarkers in peripheral blood mononuclear cells (PBMCs) for predicting irAEs in cancer patients receiving ICI therapy.
  • To validate the predictive capability of identified biomarkers for irAEs.
  • To inform precise management and targeted treatment strategies for irAEs.

Main Methods:

  • Whole transcriptomic RNA sequencing of PBMCs from cancer patients treated with PD-1/PD-L1 blockade.
  • Validation of candidate biomarkers using RT-PCR.
  • IrAEs-free survival analysis and subgroup analysis.
  • Development of LASSO regression prediction classifiers.

Main Results:

  • Transcriptomic profiles of PBMCs differentiated irAEs patients from non-irAEs patients.
  • Five candidate biomarkers identified: FXYD7, SPSB2, SLC35E2A, C2, and SERPING1.
  • Biomarker expression levels correlated with irAEs-free survival and severity.
  • Prediction classifiers achieved high accuracy (AUC=0.91 for all grades, AUC=0.94 for severe irAEs).

Conclusions:

  • Circulating immunological determinants in PBMCs are crucial for irAEs.
  • Identified biomarkers show promise for predicting irAEs in ICI-treated cancer patients.
  • These biomarkers can guide future precise management and targeted treatment strategies for irAEs.